Liang B et al.Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.J Virol 90:10022-10038 (2016).
Liang B et al.Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate.J Virol 89:9499-510 (2015).
Mackow N et al.Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine.J Virol 89:10319-32 (2015).
Nguyen PQ et al.Antiviral Cystine Knot a-Amylase Inhibitors from Alstonia scholaris.J Biol Chem 290:31138-50 (2015).
Liang B et al.Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection.J Virol 88:4237-50 (2014).
Krzyzaniak MA et al.Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the f protein.PLoS Pathog 9:e1003309 (2013).